Skip to main content
. 2015 Aug 22;7(1):89. doi: 10.1186/s13148-015-0119-8

Table 3.

Sensitivity and specificity of markers in EBNA1 positive NPC samples (n = 36) and non-cancerous controls (n = 18) from Morocco using modified MMSP assay

Marker gene Sensitivity %(positive cases/total) Specificity % (total cases − positive cases/total control cases)
U-LMP1 72 (26/36) 94 (17/18)
M-ITGA9 56 (20/36) 100 (18/18)
M-RASSF1A 78 (28/36) 94 (17/18)
M-P16 50 (18/36) 100 (18/18)